$5.61 -$0.10 (-1.8%)

04:00 PM EDT on 08/23/19

Pacific Biosciences of California, Inc. (NASDAQ:PACB)

CAPS Rating: 2 out of 5

Current Price $5.61 Mkt Cap $880.9M
Open $5.70 P/E Ratio 0.00
Prev. Close $5.71 Div. (Yield) $0.00 (0.0%)
Daily Range $5.58 - $5.79 Volume 1,937,118
52-Wk Range $5.03 - $7.50 Avg. Daily Vol. 40

Caps

How do you think NASDAQ:PACB will perform against the market?

Add Stock to CAPS Watchlist

All Players

180 Outperform
28 Underperform
 

All-Star Players

34 Outperform
12 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top NASDAQ:PACB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Breq (73.04)
Submitted July 19, 2016

The rational is the same as for Illumina. Genome sequencing will take on greater and greater importance in the future.

TSIF (99.97)
Submitted October 05, 2015

Releasing a lower cost option should ultimately be good for the bottom line...at least in this case.Sometimes too many models confuses customers and erodes the higher margin upper end of the offering, but in this case, the high end was so high,… More

NASDAQ:PACB VS S&P 500 (SPY)

Fools bullish on NASDAQ:PACB are also bullish on:

Fools bearish on NASDAQ:PACB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PACB.

Recs

0
Member Avatar FVelociraptor (99.93) Submitted: 7/26/2019 12:44:12 PM : Underperform Start Price: $5.24 NASDAQ:PACB Score: -12.79

https://velociraptor.cc

Recs

1
Member Avatar Breq (73.04) Submitted: 7/19/2016 2:25:45 PM : Outperform Start Price: $7.79 NASDAQ:PACB Score: -59.79

The rational is the same as for Illumina. Genome sequencing will take on greater and greater importance in the future.

Recs

0
Member Avatar tmjlowe (< 20) Submitted: 1/24/2015 11:17:27 PM : Outperform Start Price: $7.92 NASDAQ:PACB Score: -68.22

Their new chemistries developed for their genome long-read sequencing machines are being recognized as being the best way now to completely sequences new genomes (better than Illumina, which has trounced them up until now). This stock could really improve this year as more people recognize this is the best way to sequence new genomes.

Leaderboard

Find the members with the highest scoring picks in PACB.

Score Leader

TMFVelvetHammer

TMFVelvetHammer (66.96) Score: +503.36

The Score Leader is the player with the highest score across all their picks in PACB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jewbie 99.69 7/21/2011 Underperform 5Y $11.94 -53.01% +111.64% +164.65 0 Comment
IdahoAve 80.43 11/28/2012 Outperform 5Y $1.61 +248.45% +103.68% +144.77 0 Comment
codyjr002 82.69 8/22/2012 Outperform 5Y $1.81 +209.94% +101.63% +108.32 0 Comment
Hellespont 65.18 1/16/2018 Outperform 5Y $2.73 +105.49% +1.90% +103.59 0 Comment
PauloJSantos < 20 7/31/2012 7/28/2013 Outperform 3Y $1.84 +204.89% +105.50% +99.39 0 Comment
WiseChoice4u2 41.99 11/8/2017 Outperform 5Y $2.75 +104.37% +10.12% +94.25 0 Comment
hayrettin 70.62 6/7/2018 Outperform 5Y $2.87 +95.47% +2.69% +92.78 0 Comment
cchigga 89.18 1/26/2012 Underperform 3W $4.63 +21.17% +113.79% +92.62 0 Comment
AFMS 20.35 8/31/2012 Outperform 5Y $1.92 +192.49% +101.20% +91.29 0 Comment
ironhide196 66.14 1/31/2012 Underperform 3Y $4.39 +27.79% +115.62% +87.83 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 84.71 10/23/2015 Outperform NS $7.75 -27.61% +37.35% -64.96 0 Comment
TrackPiperJaff 84.71 7/27/2012 Underperform NS $1.77 +346.61% +51.20% -295.41 10/23/2015 @ $7.91 0 Comment
TrackJimCramer 86.36 6/24/2011 Outperform 3W $11.32 -50.44% +124.48% -174.92 0 Comment
TrackDeutscheSec 80.83 12/6/2010 Outperform NS $13.33 -57.91% +132.09% -190.01 0 Comment